<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02322892</url>
  </required_header>
  <id_info>
    <org_study_id>2014P000257</org_study_id>
    <nct_id>NCT02322892</nct_id>
  </id_info>
  <brief_title>Thiamine as an Adjunctive Therapy in Cardiac Surgery</brief_title>
  <official_title>Thiamine as an Adjunctive Therapy in Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this pilot study is to test the effects of thiamine (vitamin B1)
      administration before and after major cardiac surgery. Half of patients will receive thiamine
      and the other half will receive placebo.

      The investigators' main hypothesis is that thiamine will improve cellular oxygen consumption
      and lead to decreased levels of post-operative lactate levels and ultimately improved patient
      outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over 230,000 patients in the United States undergo Coronary Artery Bypass Grafting (CABG)
      each year. While mortality is relatively low, morbidity remains substantial with a
      significant risk of prolonged time on mechanical ventilation, prolonged length of hospital
      and intensive care unit stay and many other complications. CABG causes a profound stress
      response and significant metabolic alterations occur, including a shift from aerobic to
      anaerobic metabolism, causing increased levels of pyruvate and lactate. Elevated lactate, a
      marker of anaerobic metabolism, is a common and significant finding in patients after CABG
      and is correlated with increased mortality and morbidity.

      Aerobic metabolism occurs when pyruvate enters the mitochondria through pyruvate
      decarboxylation to acetyl-Coenzyme A, facilitated by the enzyme pyruvate dehydrogenase (PDH).
      Decreased PDH activity may cause a shift toward anaerobic metabolism and play a role in the
      changes seen in patients undergoing CABG. Thiamine (vitamin B1) is a key co-factor for PDH
      function and will increase activity even in non-deficient states. The investigators
      hypothesize that thiamine administration will increase PDH activity in patients undergoing
      CABG, leading to increased cellular oxygen consumption, as represented by decreased lactate
      levels after surgery, and ultimately improved clinical outcomes.

      In order to test the investigators' hypothesis and to obtain data for a large-scale clinical
      trial evaluating relevant clinical endpoints, the investigators are conducting a randomized,
      double-blind, pilot trial of thiamine in high-risk patients undergoing CABG.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lactate Levels</measure>
    <time_frame>Post-surgery within 1 hour of arrival to the ICU</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage Change From Baseline in Pyruvate Dehydrogenase (PDH) Enzyme Activity</measure>
    <time_frame>Post-surgery within 1 hour of arrival to the ICU</time_frame>
    <description>PDH activity will be measured in isolated peripheral blood mononuclear cells using a novel immunocapture and microplate-based method. Reported as relative change from before the surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients With Post-operative Complications</measure>
    <time_frame>Until hospital discharge, limit 60 days</time_frame>
    <description>Atrial fibrillation, delirium, renal failure, stroke, myocardial infarction, acute respiratory distress syndrome, infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay</measure>
    <time_frame>Until hospital discharge, limit 60 days</time_frame>
    <description>Duration of intensive care unit stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Until hospital discharge, limit 60 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Lactate Levels</measure>
    <time_frame>Six hours after end of surgery surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Pyruvate Dehydrogenase (PDH) Enzyme Activity</measure>
    <time_frame>Six hours after end of surgery surgery</time_frame>
    <description>PDH activity will be measured in isolated peripheral blood mononuclear cells using a novel immunocapture and microplate-based method</description>
  </other_outcome>
  <other_outcome>
    <measure>Time on Mechanical Ventilation</measure>
    <time_frame>Limit 60 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Time on Vasopressors</measure>
    <time_frame>Limit 60 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Global Oxygen Consumption (VO2)</measure>
    <time_frame>From arrival to ICU to extubation, limit 6 hours</time_frame>
    <description>VO2 will be measured with a Compact Anesthesia monitor</description>
  </other_outcome>
  <other_outcome>
    <measure>Cellular Oxygen Consumption</measure>
    <time_frame>Post-surgery within 1 hour of arrival to the ICU</time_frame>
    <description>Cellular (peripheral blood mononuclear cells) oxygen consumption measured with the XFe24 Extracellular Flux Analyzers</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Coronary Artery Bypass</condition>
  <condition>Cardiac Surgical Procedures</condition>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>50 mL normal saline solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thiamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>200 mg thiamine in 50 mL normal saline solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thiamine</intervention_name>
    <description>200 mg thiamine in 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
    <arm_group_label>Thiamine</arm_group_label>
    <other_name>vitamin B1</other_name>
    <other_name>Thiamin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline solution</intervention_name>
    <description>50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
    <arm_group_label>Control Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (â‰¥ 21 years)

          -  Coronary artery bypass grafting (CABG) with or without concomitant valve procedures

          -  EuroSCORE II &gt; 1.5%

        Exclusion Criteria:

          -  Current thiamine supplementation

          -  Known allergy to thiamine

          -  Competing indication for thiamine administration as judged by the clinical team (e.g.,
             alcoholic)

          -  Research-protected populations (pregnant women, prisoners, the intellectually
             disabled)

          -  Emergent or salvage CABG (as defined by the Society of Thoracic Surgeons)

          -  Off-pump surgery (i.e. surgery without cardiopulmonary bypass)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael W Donnino, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2014</study_first_submitted>
  <study_first_submitted_qc>December 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2014</study_first_posted>
  <results_first_submitted>April 7, 2016</results_first_submitted>
  <results_first_submitted_qc>March 3, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 30, 2017</results_first_posted>
  <last_update_submitted>March 3, 2017</last_update_submitted>
  <last_update_submitted_qc>March 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beth Israel Deaconess Medical Center</investigator_affiliation>
    <investigator_full_name>Michael Donnino</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Thiamine</keyword>
  <keyword>Vitamin B1</keyword>
  <keyword>Coronary artery bypass grafting</keyword>
  <keyword>Cardiac surgery</keyword>
  <keyword>Lactate</keyword>
  <keyword>Pyruvate dehydrogenase</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Thiamine</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>275 coronary artery bypass grafting patients screened between January and July 2015</recruitment_details>
      <pre_assignment_details>206 patients not included for various reasons. 5 patients were randomized, but never received the assigned treatment and was therefore not included in the pre-specified modified intend-to-treat analysis.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Control Arm</title>
          <description>50 mL normal saline solution
Normal saline solution: 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
        </group>
        <group group_id="P2">
          <title>Thiamine</title>
          <description>200 mg thiamine in 50 mL normal saline solution
Thiamine: 200 mg thiamine in 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35">Number randomized</participants>
                <participants group_id="P2" count="34">Number randomized</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33">Received placebo</participants>
                <participants group_id="P2" count="31">Received thiamine</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Surgery cancelled</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Met exclusion criteria</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Modified intention to treat analysis</population>
      <group_list>
        <group group_id="B1">
          <title>Control Arm</title>
          <description>50 mL normal saline solution
Normal saline solution: 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
        </group>
        <group group_id="B2">
          <title>Thiamine</title>
          <description>200 mg thiamine in 50 mL normal saline solution
Thiamine: 200 mg thiamine in 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
            <count group_id="B2" value="31"/>
            <count group_id="B3" value="64"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73" lower_limit="68" upper_limit="79"/>
                    <measurement group_id="B2" value="71" lower_limit="67" upper_limit="75"/>
                    <measurement group_id="B3" value="72" lower_limit="67" upper_limit="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Lactate Levels</title>
        <time_frame>Post-surgery within 1 hour of arrival to the ICU</time_frame>
        <population>Modified intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Control Arm</title>
            <description>50 mL normal saline solution
Normal saline solution: 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
          </group>
          <group group_id="O2">
            <title>Thiamine</title>
            <description>200 mg thiamine in 50 mL normal saline solution
Thiamine: 200 mg thiamine in 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
          </group>
        </group_list>
        <measure>
          <title>Lactate Levels</title>
          <population>Modified intention to treat</population>
          <units>mmol/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="1.7" upper_limit="2.4"/>
                    <measurement group_id="O2" value="2.0" lower_limit="1.5" upper_limit="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage Change From Baseline in Pyruvate Dehydrogenase (PDH) Enzyme Activity</title>
        <description>PDH activity will be measured in isolated peripheral blood mononuclear cells using a novel immunocapture and microplate-based method. Reported as relative change from before the surgery.</description>
        <time_frame>Post-surgery within 1 hour of arrival to the ICU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Arm</title>
            <description>50 mL normal saline solution
Normal saline solution: 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
          </group>
          <group group_id="O2">
            <title>Thiamine</title>
            <description>200 mg thiamine in 50 mL normal saline solution
Thiamine: 200 mg thiamine in 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Change From Baseline in Pyruvate Dehydrogenase (PDH) Enzyme Activity</title>
          <description>PDH activity will be measured in isolated peripheral blood mononuclear cells using a novel immunocapture and microplate-based method. Reported as relative change from before the surgery.</description>
          <units>Percent change from baseline</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" lower_limit="15" upper_limit="84"/>
                    <measurement group_id="O2" value="15" lower_limit="11" upper_limit="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patients With Post-operative Complications</title>
        <description>Atrial fibrillation, delirium, renal failure, stroke, myocardial infarction, acute respiratory distress syndrome, infection</description>
        <time_frame>Until hospital discharge, limit 60 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Arm</title>
            <description>50 mL normal saline solution
Normal saline solution: 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
          </group>
          <group group_id="O2">
            <title>Thiamine</title>
            <description>200 mg thiamine in 50 mL normal saline solution
Thiamine: 200 mg thiamine in 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
          </group>
        </group_list>
        <measure>
          <title>Patients With Post-operative Complications</title>
          <description>Atrial fibrillation, delirium, renal failure, stroke, myocardial infarction, acute respiratory distress syndrome, infection</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay</title>
        <description>Duration of intensive care unit stay</description>
        <time_frame>Until hospital discharge, limit 60 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Arm</title>
            <description>50 mL normal saline solution
Normal saline solution: 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
          </group>
          <group group_id="O2">
            <title>Thiamine</title>
            <description>200 mg thiamine in 50 mL normal saline solution
Thiamine: 200 mg thiamine in 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay</title>
          <description>Duration of intensive care unit stay</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" lower_limit="1.4" upper_limit="4.0"/>
                    <measurement group_id="O2" value="2.4" lower_limit="1.1" upper_limit="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mortality</title>
        <time_frame>Until hospital discharge, limit 60 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Arm</title>
            <description>50 mL normal saline solution
Normal saline solution: 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
          </group>
          <group group_id="O2">
            <title>Thiamine</title>
            <description>200 mg thiamine in 50 mL normal saline solution
Thiamine: 200 mg thiamine in 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
          </group>
        </group_list>
        <measure>
          <title>Mortality</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Lactate Levels</title>
        <time_frame>Six hours after end of surgery surgery</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Pyruvate Dehydrogenase (PDH) Enzyme Activity</title>
        <description>PDH activity will be measured in isolated peripheral blood mononuclear cells using a novel immunocapture and microplate-based method</description>
        <time_frame>Six hours after end of surgery surgery</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Time on Mechanical Ventilation</title>
        <time_frame>Limit 60 days</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Time on Vasopressors</title>
        <time_frame>Limit 60 days</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Global Oxygen Consumption (VO2)</title>
        <description>VO2 will be measured with a Compact Anesthesia monitor</description>
        <time_frame>From arrival to ICU to extubation, limit 6 hours</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cellular Oxygen Consumption</title>
        <description>Cellular (peripheral blood mononuclear cells) oxygen consumption measured with the XFe24 Extracellular Flux Analyzers</description>
        <time_frame>Post-surgery within 1 hour of arrival to the ICU</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control Arm</title>
          <description>50 mL normal saline solution
Normal saline solution: 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
        </group>
        <group group_id="E2">
          <title>Thiamine</title>
          <description>200 mg thiamine in 50 mL normal saline solution
Thiamine: 200 mg thiamine in 50 mL normal saline once immediately before surgery and once immediately after (at arrival in the intensive care unit)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Lars W. Andersen</name_or_title>
      <organization>Beth Israel Deaconess Medical Center</organization>
      <phone>6173886343</phone>
      <email>larswiuffandersen@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

